Neuroprotection by immunomodulatory agents in animal models of Parkinson's diseaseBridget Martinez, Philip V.Peplow1493-1506
Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitisYuan Yue, Sarrabeth Stone, Wensheng Lin1507-1515
Nanometer ultrastructural brain damage following low intensity primary blast wave exposureHailong Song, Landry M.Konan, Jiankun Cui, Catherine E.Johnson, Graham K.Hubler, Ralph G.DePalma, Zezong Gu1516-1519
Seeing the wood for the trees: towards improved quantification of glial cells in central nervous system tissueSinéad Healy, Jill McMahon, Una FitzGerald1520-1523
Altered leukocyte gene expression after traumatic spinal cord injury: clinical implicationsPaige E.Herman, Ona Bloom1524-1529
Promoting axonal regeneration following nerve surgery: a perspective on ultrasound treatment for nerve injuriesKonstantin D.Bergmeister, Simeon C.Daeschler, Patrick Rhodius, Philipp Schoenle, Arne B(o)cker, Ulrich Kneser, Leila Harhaus1530-1533
Schwann cell Myc-interacting zinc-finger protein 1 without pox virus and zinc finger: epigenetic implications in a peripheral neuropathyDavid Fuhrmann, Hans-Peter Els(a)sser1534-1537
Utilizing zebrafish and okadaic acid to study Alzheimer's diseaseDaniel Koehler, Frederick E.Williams1538-1541
The emerging epigenetics of PARK7 and its implication in neurodegenerative diseaseGeorge D.Vavougios, Sotirios G.Zarogiannis1542-1543
